ドイツのマルチプレックスアッセイ市場

出版：Inkwood Research

GERMANY MULTIPLEX ASSAY MARKET FORECAST 2021-2026

–

このレポートへお問合せ　　　レポート目次

Inkwood Research「GERMANY MULTIPLEX ASSAY MARKET FORECAST」はドイツのマルチプレックスアッセイ市場を分析・予測した市場調査レポートです。

KEY FINDINGS
The Germany multiplex assay market is projected to register a CAGR of 8.90% over the forecast years. The developments within the pharmaceutical industry, as well as the partnerships and collaborations of clinical trials, are among the key factors associated with the market growth of the country. While the base year considered for the market study is 2020, the estimated period is from 2021 to 2026.
MARKET INSIGHTS
Multiplex assays deliver convenient, automated, and faster disease analysis, as compared to traditional methods. Moreover, they are largely used for mutation analysis, pathogen identification, gene detection analysis, forensic studies, RNA detection, linkage analysis, and others. Germany is one of the leading destinations for pharmaceutical research and development (R&D) globally. According to the 2019 report by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the country invested approximately EUR 6,918 million in pharmaceutical R&D in 2017. Hence, these aspects result in an increasing number of drug discoveries and developments, playing a vital role in fueling the country’s demand for digital PCR technology. Furthermore, extensive research activities across the German pharmaceutical industry are set to fuel the usage of digital PCR, as well.
On the other hand, the government of Germany provides infrastructural support for domestic and foreign multinational companies in order to establish new manufacturing centers and expand existing R&D sites. Therefore, the abovementioned factors are evaluated to fuel the multiplex assay market growth in the country over the forecasting period.
COMPETITIVE INSIGHTS
Some of the leading enterprises operating in the market are Siemens Healthineers AG, Agilent Technologies Inc, Qiagen NV, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. PORTER’S FIVE FORCES ANALYSIS
3.1.1. THREAT OF NEW ENTRY
3.1.2. THREAT OF SUBSTITUTION
3.1.3. BUYER’S POWER
3.1.4. SUPPLIER’S POWER
3.1.5. COMPETITIVE RIVALRY
3.2. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
3.3. REGULATORY FRAMEWORK
3.4. OPPORTUNITY MATRIX
3.5. VENDOR LANDSCAPE
4. MARKET BY TYPE
4.1. PROTEIN-BASED MULTIPLEX ASSAY
4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
4.3. OTHER MULTIPLEX ASSAYS
5. MARKET BY PRODUCT
5.1. REAGENTS AND CONSUMABLES
5.2. INSTRUMENTS AND ACCESSORIES
5.3. SOFTWARE AND SERVICES
6. MARKET BY TECHNOLOGY
6.1. MULTIPLEX PROTEIN MICROARRAY
6.2. MULTIPLEX PCR
6.3. OTHER TECHNOLOGIES
7. MARKET BY APPLICATION
7.1. CLINICAL DIAGNOSTICS
7.2. RESEARCH AND DEVELOPMENT
7.3. COMPANION DIAGNOSTICS
8. MARKET BY END-USER
8.1. HOSPITALS
8.2. CLINICAL LABORATORIES
8.3. RESEARCH INSTITUTES
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
9.1.4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
9.2. COMPANY PROFILES
9.2.1. AGILENT TECHNOLOGIES INC
9.2.2. F. HOFFMANN-LA ROCHE
9.2.3. QIAGEN NV
9.2.4. RANDOX LABORATORIES LTD
9.2.5. SIEMENS HEALTHINEERS AG

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY
TABLE 2: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 8: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 10: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
TABLE 15: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

List of Figures

LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
FIGURE 5: GERMANY MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2026 (IN $ MILLION)
FIGURE 6: GERMANY MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2026 (IN $ MILLION)
FIGURE 7: GERMANY MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2026 (IN $ MILLION)
FIGURE 8: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
FIGURE 9: GERMANY MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2026 (IN $ MILLION)
FIGURE 10: GERMANY MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2026 (IN $ MILLION)
FIGURE 11: GERMANY MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2026 (IN $ MILLION)
FIGURE 12: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
FIGURE 13: GERMANY MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2026 (IN $ MILLION)
FIGURE 14: GERMANY MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2026 (IN $ MILLION)
FIGURE 15: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 16: GERMANY MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2026 (IN $ MILLION)
FIGURE 17: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
FIGURE 18: GERMANY MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2026 (IN $ MILLION)
FIGURE 19: GERMANY MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2026 (IN $ MILLION)
FIGURE 20: GERMANY MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2026 (IN $ MILLION)
FIGURE 21: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
FIGURE 22: GERMANY MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2026 (IN $ MILLION)
FIGURE 23: GERMANY MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2026 (IN $ MILLION)
FIGURE 24: GERMANY MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2026 (IN $ MILLION)
FIGURE 25: GERMANY MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2026 (IN $ MILLION)

お問合せフォーム